Clinical Trials Browser

Has results × Keratosis × Imiquimod × Clear all

NCT00116649 2010-07-20

Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis

Phase 4 Completed

551 enrolled 11 charts

Keratosis, Keratosis, Actinic